Fuan Pharmaceutical (300194.SZ) issues a profit warning, expecting the net profit attributable to the parent company in the first half of the year to be between 1 billion and 1.3 billion yuan, a year-on-year decrease of 39.95% to 53.81%.

Zhtng Cijng APP news, Fu'an Pharmaceutical (300194.SZ) disclosed the performance forecast for the first half of 2025. The company expects a net profit attributable to shareholders of the listed company of 1 to 1.3 billion yuan, a year-on-year decrease of 39.95% to 53.81%; net profit after deducting non-recurring gains and losses is expected to be 91 to 121 million yuan, a year-on-year decrease of 40.50% to 55.25%.